
- July 2019 Gastrointestinal Issues
- Volume 85
- Issue 7
Expanding the Role of Pharmacists in the Administration of Long-Acting Injectable Antipsychotic Medications
Continuing education for administration of long-acting injectable antipsychotic medications.
Faculty
Misty L. Gonzalez, PharmD, BCPP, Clinical Associate Professor, Southern Illinois University, Edwardsville School of Pharmacy, Edwardsville, Illinois
Danielle Moses, PharmD, BCPP, Psychiatric Pharmacist, SSM Health DePaul Hospital, St. Louis, Missouri
Educational Objectives
At the completion of this activity, the participant will be able to:
- Examine nonadherence data among patients with mental illness
- Identify legislative changes that have expanded the role of pharmacists in providing long-acting injectable antipsychotic (LAIA) medications to patients
- Explore FDA-approved formulations and administration of LAIAs
- Demonstrate the appropriate administration of LAI therapies in practice
Target Audience: Pharmacists
Activity Type: Application
Release Date: July 19, 2019
Expiration Date: July 19, 2020
Estimated Time to Complete Activity: 2.5 hours
Fee: This lesson is offered for free at
Articles in this issue
over 6 years ago
Pharmacy Law: Pharmacist and Assistant Are Indicted on Chargesover 6 years ago
Reporting and Second-Order Problem Solving Are Criticalover 6 years ago
Norovirus Presents Patient Care Obstaclesover 6 years ago
OTC Case Studies: Stomach Issuesover 6 years ago
Counsel Patients About the Symptoms of Celiac Diseaseover 6 years ago
Consider Interactions With Analgesics When Treating Neuropathiesover 6 years ago
Case Studies (July 2019)Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


















































































































































































































